Myelodysplastic Syndrome — Trials

Myelodysplastic Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

1,702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 336
Recruiting: 196
Ph III recruiting: 9
Growth YoY: +2.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 33.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (307)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07814170	A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece	active not recruiting	N/A	80	University of West AtticaOTHER	1	Sep 10, 2026	clinicaltrials
NCT04482894	Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS	active not recruiting	N/A	105	University of VirginiaOTHER	1	May 4, 2026	clinicaltrials